My Computational Radiation Biology and Oncology Lab
@RadNetCRUKCoL@UCLmedphys@uclcancer will soon advertise for a postdoc to work on mathematical/statistical modelling to optimise drug-radiation combination therapy schedules. DM me to discuss. Please RT. #mathonco#radonc
Just published! We proudly present "Hallmarks of Cancer: New Dimensions" by Douglas Hanahan, the third update to the seminal series. https://t.co/bSer4maIjF @Ludwig_Cancer
Fascinating new insights into how cancer cells use and switch between different mechanisms of focal gene amplification (extra-chromosomal vs intra-chromosomal) to evolve resistance to drug treatment. Beautiful work by @graeber_thomas and team! https://t.co/33x2i9StwC
My Computational Radiation Biology and Oncology Lab @RadNetCRUKCoL@UCLmedphys@uclcancer is seeking a postdoc to work on theoretical modelling (integrated with experimental data) of glioblastoma radiotherapy resistance: https://t.co/LBSZ6qa0LC
DM me to discuss. Please RT.
Herculean effort from @KamPoels+colleagues to initiate a clinical trial based on a validated model of combination therapy in lung cancer. Happy to have contributed in the initial stages of model development and to see this finally out in @NatureComms. https://t.co/ZRJyrqFlTq
New study demonstrating reversal in national PPI prescribing trends using Medicare data with all specialties showing a decrease in the average number of claims per beneficiary 💊
https://t.co/xspaUlaAyU
@KamPoels@nyulangone@HarvardChanSPH
2/2 Also, colon ca more likely than rectal ca to be diagnosed at Stage 4⃣
@nyulangone@HarvardChanSPH@DeptVetAffairs
Demographics Predict Stage III/IV Colorectal Cancer in... : Journal of Clinical Gastroenterology https://t.co/y0xyD5R5j2
1/2 Our new study led by @oferfass found that among 🇺🇸patients diagnosed with early-onset #colorectalcancer (age <50):
1) younger age
2) Asian, black, or Pacific Islander race
3) not having a partner
were associated with having advanced (Stage 3⃣/4⃣) disease